NO COMPROMISE - Amyris, Inc. Trademark Registration

Definitive Proxy Statement

Definitive Proxy Statement

Amyris Biotechnology Company

Director, Human Resources (2494) at Amyris

Amyris Completes First Major License For Leading RNA Vaccine Advancing Technology To Human Trials

NO COMPROMISE - Amyris, Inc. Trademark Registration

New Research & Regulations Support Amyris' Mission - Amyris

Royal DSM to make equity investment in Amyris with the purpose of establishing a long-term relationship

amrs-20211231

Amyris Presents Its No Compromise™ Product Portfolio at

Document

Amyris Appoints Sheila Shekar Pollak As Chief Marketing Officer Of Biossance

Amyris Delivering Sustainable Alternative To Shark Squalene Adjuvant - Enabling Vaccines For All With No Sharks Killed - SynBioBeta